Pembrolizumab and Cabozantinib in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma (RMHNSCC): 2-year Long Term Survival Update with Biomarker Analysis

被引：0
|
作者：
Saba, N. F. [1 ]
Ekpenyong, A. [1 ]
McCook, A. [1 ]
Schmitt, N. C. [1 ]
Gross, J. H. [1 ]
Rudra, S. F. [1 ]
Stokes, W. A. [2 ]
Kirtane, K. [3 ]
Chaudhary, R. [4 ]
Biernacki, M. [4 ]
Slebos, R. [4 ]
Song, X. [4 ]
Steuer, C. [5 ]
Shin, D. M. [5 ]
Teng, Y. F. [1 ]
Liu, Y. [6 ]
Chung, C. H. [3 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Atlanta, GA 30322 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[6] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2
引用
收藏
页码：E3 / E3
页数：1
相关论文
共 50 条
  • [1] A phase II trial of pembrolizumab and cabozantinib in patients (pts) with recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC).
    Saba, Nabil F.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Patel, Mihir
    Schmitt, Nicole Cherie
    Stokes, William A.
    Bates, James Edward
    Rudra, Soumon
    Abousaud, Marin Ibrahim
    Muzaffar, Jameel
    Kirtane, Kedar
    Teng, Yong
    Steuer, Conor Ernst
    Shin, Dong Moon
    Liu, Yuan
    Chung, Christine H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
    Saba, Nabil F.
    Steuer, Conor E.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Magliocca, Kelly
    Patel, Mihir
    Schmitt, Nicole C.
    Stokes, William
    Bates, James E.
    Rudra, Soumon
    Remick, Jill
    McDonald, Mark
    Abousaud, Marin
    Tan, Aik Choon
    Fadlullah, Muhammad Zaki Hidayatullah
    Chaudhary, Ritu
    Muzaffar, Jameel
    Kirtane, Kedar
    Liu, Yuan
    Chen, Georgia Z.
    Shin, Dong M.
    Teng, Yong
    Chung, Christine H.
    [J]. NATURE MEDICINE, 2023, 29 (04) : 880 - 887
  • [3] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, H-F.
    Hong, R-L.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 379 - 379
  • [4] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, Hsiang-Fong
    Huang, Huai-Cheng
    Liao, Bin-Chi
    Hong, Ruey-Long
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [5] Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
    Chen, Wen-Chun
    Chu, Pen-Yuan
    Lee, Yu-Ting
    Lu, Wen-Bin
    Liu, Chun-Yu
    Chang, Peter Mu-Hsin
    Yang, Muh-Hwa
    [J]. MEDICINE, 2017, 96 (52)
  • [6] Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial (vol 29, pg 880, 2023)
    Saba, Nabil F.
    Steuer, Conor E.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Magliocca, Kelly
    Patel, Mihir
    Schmitt, Nicole C.
    Stokes, William
    Bates, James E.
    Rudra, Soumon
    Remick, Jill
    Mcdonald, Mark
    Abousaud, Marin
    Tan, Aik Choon
    Fadlullah, Muhammad Zaki Hidayatullah
    Chaudhary, Ritu
    Muzaffar, Jameel
    Kirtane, Kedar
    Liu, Yuan
    Chen, Georgia Z.
    Shin, Dong M.
    Teng, Yong
    Chung, Christine H.
    [J]. NATURE MEDICINE, 2024, 30 (08) : 2373 - 2373
  • [7] Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma
    Iwaki, Sho
    Kadowaki, Shigenori
    Honda, Kazunori
    Narita, Yukiya
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Ando, Masashi
    Muro, Kei
    Sawabe, Michi
    Suzuki, Hidenori
    Nishikawa, Daisuke
    Beppu, Shintaro
    Terada, Hoshino
    Kishikawa, Toshihiro
    Kawakita, Daisuke
    Hanai, Nobuhiro
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (06) : 764 - 770
  • [8] Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis
    Kao, Hsiang-Fong
    Liao, Bin-Chi
    Huang, Yen-Lin
    Huang, Huai-Cheng
    Chen, Chun-Nan
    Chen, Tseng-Cheng
    Hong, Yuan-Jing
    Chan, Ching-Yi
    Chia, Jean-San
    Hong, Ruey-Long
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (08) : 1560 - 1571
  • [9] Pembrolizumab for cisplatin-failure recurrent/metastatic head and neck squamous cell carcinoma
    Chen, W-C.
    Chang, P. M-H.
    Lee, Y-T.
    Lu, W-B.
    Yang, M-H.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [10] Afatinib and pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma (ALPHA Study): A phase II study with biomarker analysis.
    Kao, Hsiang-fong
    Liao, Bin-Chi
    Huang, Yen-Lin
    Huang, Huai-Cheng
    Chen, Chun-Nan
    Chen, Tseng-Cheng
    Hong, Yuan-Jing
    Chan, Ching-Yi
    Hong, Ruey-Long
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345